DEA Sets New Import, Export Restrictions for Amineptine

The Drug Enforcement Administration is listing amineptine, a synthetic tricyclic antidepressant with central nervous system (CNS) stimulating properties, under Schedule I of the Controlled Substances Act, it said in a notice released Nov. 16. “This action imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess), or propose to handle, amineptine," DEA said. The listing takes effect Dec. 19.